NewRegen Experiences Significant Growth in the Health and Wellness Space

3 years ago

ATLANTA, GA, June 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – NewRegen (OTC:NREG), a leading comprehensive wellness services company, today…

Veru Inc.’s Oncology Drug Research Program Partner, The University of Tennessee Health Science Center, Awarded Two New Federal Grants

3 years ago

Research grants from U.S. Department of Defense (DoD) and National Cancer Institute’s Research Project Grant (NCI R01) awarded to UTHSC…

CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath

3 years ago

BERKELEY HEIGHTS, N.J., June 21, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…

Cigna Expands Coverage of Glaucoma Surgical Procedures to Include Canaloplasty and Goniotomy (Trabeculotomy)

3 years ago

OMNI Device OMNI DeviceCigna has close to 15 million covered lives Cigna’s Coverage Policy includes procedures enabled with OMNI® Surgical…

BrainsWay Announces Significant Expansion in Western and Central U.S.

3 years ago

30 Deep TMS™ Devices Ordered by Large Mental Health-Focused TMS NetworkBURLINGTON, Mass. and JERUSALEM, June 21, 2023 (GLOBE NEWSWIRE) --…

Positive Preclinical Data of ORY-4001 for the Treatment of Charcot-Marie-Tooth (CMT) Disease Presented at the 2023 Peripheral Nerve Society (PNS) Annual Meeting

3 years ago

Comprehensively reversed disease progression symptoms in a CMT mice modelSelected for an oral presentationA highly selective and safe HDAC-6 inhibitorTo…

Retrieve Medical. Inc. Announces New Contract with Healthcare Enterprise Technology Company

3 years ago

BEDMINSTER, N.J., June 21, 2023 (GLOBE NEWSWIRE) -- Retrieve Medical, Inc. (OTC: RMHI) today announced that they have signed an…

Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases

3 years ago

WAKEFIELD, MA, June 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical…